| SR Group (n = 69) | PRFA Group (n = 162) | P value |
---|---|---|---|
Gender | Â | Â | Â |
   Male | 50 | 95 | 0.054 |
   Female | 19 | 67 |  |
Age | 67.4 ± 9.7 | 68.4 ± 8.7 | 0.45 |
Tumor size (cm) | 2.68 ± 0.49 | 1.9 9 ± 0.62 | 0.001 |
Etiology of liver disease | Â | Â | Â |
   chronic hepatitis B | 8 | 9 | 0.182 |
   chronic hepatitis C | 51 | 135 |  |
   non B, non C | 10 | 18 |  |
Child-Pugh classification | Â | Â | Â |
   chronic hepatitis | 19 | 35 | 0.285 |
   Child-Pugh A | 45 | 102 |  |
   Child-Pugh B | 5 | 22 |  |
   Child-Pugh C | 0 | 3 |  |
Total-Bilirubin (mg/dL) | 0.84 ± 0.48 | 0.93 ± 0.51 | 0.182 |
Serum albumin (g/dL) | 3.89 ± 0.52 | 3.80 ± 0.55 | 0.248 |
Platelet ((×104/mm3) | 13.4 ± 6.3 | 11.2 ± 4.8 | 0.004 |
AST (IU/L) | 58.9 ± 39.7 | 59.6 ± 34.0 | 0.897 |
ALT (IU/L) | 53.0 ± 38.8 | 51.1 ± 32.7 | 0.697 |
Prothrombin time (%) | 89.9 ± 14.9 | 87.8 ± 15.0 | 0.35 |
AFP (ng/mL) | 376.7 ± 1989.8 | 74.7 ± 181.1 | 0.056 |
PIVKAII (mAU/mL) | 739.0 ± 3900.1 | 95.5 ± 154.2 | 0.037 |